From November 3rd to 6th 2017, the Hellenic Society of Dermatology and Venereology (EDAE) held the 13th Panhellenic Conference of Dermatology & Venereology, at Makedonia Palace hotel, in Thessaloniki, capital of Northern Greece, Macedonia.
IASIS PHARMA was present, attending the conference with success.

The conference aimed to update dermatologists on the latest scientific developments in their field of expertise. The Event’s scientific program included a number of specialized lectures, round table discussions, satellite symposiums and free posts, which covered a wide range of topics, focusing in the most recent findings on diseases like psoriasis, acne, melanoma, nails and hair diseases, cosmetology, paediatric dermatology, oncology and more.

IASIS PHARMA exhibition stand was visited by the majority of the attending dermatologists, who showed great interest on three (3) of IASIS PHARMA main dermatological products:

Ιsotroin®, isotretinoin, a retinoid for the treatment of acne, is the only product of its kind in the Greek market available in soft caps of 10mg, 20mg and 40mg strength, thus helping the dermatologist to ideally customise the required dosage per patient.

Combi®, a combination of miconazole + fluprednidene in the form of a cream with excellent texture and the advantage of the 50g pack.

Acetocaustin®, monochloroacetic acid, a uniquely effective topical treatment for warts, that needs to be applied only once per week. Acetocaustin® is already marketed in 22 countries for over 30 years, being widely prescribed by dermatologists. It is distributed through pharmacies by pharma Q, an IASIS PHARMA company.